Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Protara Therapeutics Inc TARA

Healthcare Biotechnology
Protara Therapeutics, Inc. is a clinical-stage biotechnology company, which is engaged in advancing transformative therapies for people with cancer and rare diseases. The Company’s portfolio includes its lead candidate, TARA-002, an investigational cell-based therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs). The Company is... see more

Recent & Breaking News (NDAQ:TARA)

Proteon Therapeutics to Ring the Nasdaq Stock Market Opening Bell on February 9th

GlobeNewswire February 6, 2015

Proteon Therapeutics to Present at the 17th Annual BIO CEO & Investor Conference February 9th

GlobeNewswire February 5, 2015

Journal of Cardiovascular Pharmacology Publishes Positive Nonclinical Results of Proteon Therapeutics' PRT-201 in Peripheral Artery Disease

GlobeNewswire January 8, 2015

Proteon Therapeutics to Present at the Oppenheimer 25th Annual Healthcare Conference December 11th

GlobeNewswire December 8, 2014

Proteon Therapeutics Announces Third Quarter 2014 Financial Results

GlobeNewswire November 25, 2014

Proteon Therapeutics Announces the Closing of Initial Public Offering and the Underwriters' Option to Purchase Additional Shares

GlobeNewswire November 24, 2014

Proteon Therapeutics to Present at the Stifel Nicolaus 2014 Healthcare Conference November 18th

GlobeNewswire November 17, 2014